Fulcrum Therapeutics, Inc.·4

Jul 18, 5:26 PM ET

Thomson Peter G. 4

4 · Fulcrum Therapeutics, Inc. · Filed Jul 18, 2019

Insider Transaction Report

Form 4
Period: 2019-07-18
Thomson Peter G.
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2019-07-18+7,0787,078 total
    Exercise: $16.00Exp: 2029-07-17Common Stock (7,078 underlying)
Footnotes (1)
  • [F1]The option was granted on July 18, 2019. The shares underlying the option are scheduled to vest in equal quarterly installments from July 1, 2019 through June 30, 2023.

Documents

1 file
  • 4
    a4.xmlPrimary

    4